Company Filing History:
Years Active: 2023
Title: The Innovations of John Haliburton in Immuno-Binding Proteins
Introduction
John Haliburton, based in Redwood City, CA, is an accomplished inventor known for his significant contributions to the field of biomedical research. With one patent to his name, he has made strides in isolating immune binding proteins, a vital aspect of immunology and therapeutic development.
Latest Patents
Haliburton holds a patent for "Methods for isolating immune binding proteins." This patent describes novel methods for obtaining immune binding proteins from various sources, including genomic material. His innovative approach ensures that the natural multimeric associations of chains are preserved within the nucleic acids encoding these proteins. Notably, the patent emphasizes maintaining the pairing of heavy and light chains when amplifying nucleic acids from B-cells. This pioneering technique enables the formation of libraries and repertoires of immune binding proteins that are rich in beneficial binding molecules.
Career Highlights
As a key figure at Augmenta Bioworks, Inc., John Haliburton has enhanced the company's research initiatives focused on immunology and biotechnology. His work not only contributes to the scientific community but also lays the groundwork for developing new therapeutic strategies that may improve healthcare outcomes.
Collaborations
Haliburton collaborates with talented colleagues, including Marco Antonio Mena and Christopher J Emig, at Augmenta Bioworks, Inc. This collaborative environment fosters innovation and advances their collective research pursuits in immune binding proteins and related technologies.
Conclusion
John Haliburton's innovative work in isolating immune binding proteins highlights the importance of preserving protein interactions in research. His contributions not only reflect his commitment to advancing science but also exemplify the critical role of collaboration within the research community at Augmenta Bioworks, Inc. The future may hold even more groundbreaking discoveries as he continues to push the boundaries of immunological research.